Aspects of tolerability of centrally acting antihypertensive drugs.

Author: KochH F, WebsterJ

Paper Details 
Original Abstract of the Article :
Traditional centrally acting antihypertensives have been associated with a high incidence of adverse effects and are no longer recommended as first-line therapy. The newer imidazoline receptor agonists must overcome this reputation if they are to gain recognition as potential first-line agents for h...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1097/00005344-199627003-00007

データ提供:米国国立医学図書館(NLM)

Centrally Acting Antihypertensives: Navigating the Desert of Side Effects

High blood pressure, like a relentless desert wind, can put a strain on your cardiovascular system. This study explores the use of centrally acting antihypertensive drugs, which work by targeting the brain to regulate blood pressure. It's like seeking a solution to a desert storm, finding a way to calm the turbulent air.

The researchers review the history and current use of centrally acting antihypertensives, highlighting their potential benefits and drawbacks, especially in terms of side effects. This approach is like traversing a desert landscape, learning from past experiences and charting a course for the future.

A Balancing Act: Efficacy vs. Side Effects

The study emphasizes the need for a careful balance between the efficacy and tolerability of these drugs. It's like navigating a desert, finding a path that avoids the dangers of sandstorms while reaching the desired destination.

A Shift in Perspective: Seeking Safer Options

The study suggests that newer centrally acting antihypertensives, such as imidazoline receptor agonists, may offer a safer alternative to older medications. It's like discovering a new oasis in the desert, one that offers a more comfortable and reliable source of water.

Dr. Camel's Conclusion

This study provides a valuable overview of centrally acting antihypertensives, highlighting the importance of weighing their benefits and risks. By understanding the complexities of these drugs, we can make informed decisions about treatment options, ensuring that patients receive the best possible care while minimizing potential side effects.

Date :
  1. Date Completed 1997-01-03
  2. Date Revised 2022-03-30
Further Info :

Pubmed ID

8872299

DOI: Digital Object Identifier

10.1097/00005344-199627003-00007

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.